Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
What explains functioning from the perspective of people with multiple sclerosis?
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Vitamin D and multiple sclerosis.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Effects of yoga interventions on fatigue: a meta-analysis.
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
The role of information system in multiple sclerosis management.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Increased Th17 response to myelin peptides in pediatric MS.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Multiple Sclerosis: Does Nogo Play a Role?
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
LSN MS guidelines for the management of multiple sclerosis.
New hope for multiple sclerosis patients.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
[Clinical features of neuromyelitis optica and the distribution of Chinese medical syndrome types: a case report of 63 cases].
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »